An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).

Clinical trial NCT06339060 · RECRUITING

Trial details

NCT number: NCT06339060
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2024-05-01
Primary completion: 2028-03-01
Enrollment: 356

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.